Anna Sutton was shocked when she received a letter from her husband’s job-based health plan stating that Humira, an expensive drug used to treat her daughter’s juvenile arthritis, was now on a long ...

Why do pharmaceutical companies charge exorbitant rates for their products but then give them away for free or virtually no cost to most patients, regardless of income, through patient assistance ...

Specialty pharmacy workflows must account for longer, more complex affordability calls, with co-pay-shock interactions averaging ~12 minutes and requiring rapid benefit-type stratification.

On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...

In early 2019, Jennifer Hepworth and her husband were stunned by a large bill they unexpectedly received for their daughter’s prescription cystic fibrosis medication. Their payment had risen to $3,500 ...

Greater transparency and independent evaluation are needed to understand the impact of the patient support programs that pharmaceutical companies offer for many expensive drugs, according to ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting ...

When Gury Doshi, MD, learned that a patient’s insurance didn’t cover her breast cancer medication, Doshi had a potential workaround. The patient could try to bypass the insurer and access the drug at ...

Drug manufacturer Johnson & Johnson has filed a lawsuit against drug benefit company SaveOnSP for allegedly taking advantage of a J&J program that covers out-of-pocket costs for patients who use some ...

Copayment accumulators and maximizers have the potential to harm patients’ access to necessary medicines. Health care payers (including employers, insurers, and pharmacy benefit managers), regulators, ...

More than 1.2 million people in the U.S. are living with HIV. If left untreated, HIV can lead to AIDS. But with consistent medical treatment, HIV drugs can keep you healthy, and, if your HIV virus ...